THRN
Thorne Healthtech Inc
Price:  
10.19 
USD
Volume:  
84,671.00
United States | Personal Products
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

THRN WACC - Weighted Average Cost of Capital

The WACC of Thorne Healthtech Inc (THRN) is 8.0%.

The Cost of Equity of Thorne Healthtech Inc (THRN) is 8.10%.
The Cost of Debt of Thorne Healthtech Inc (THRN) is 4.25%.

Range Selected
Cost of equity 6.80% - 9.40% 8.10%
Tax rate 4.60% - 7.00% 5.80%
Cost of debt 4.00% - 4.50% 4.25%
WACC 6.7% - 9.2% 8.0%
WACC

THRN WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.64 0.81
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.80% 9.40%
Tax rate 4.60% 7.00%
Debt/Equity ratio 0.03 0.03
Cost of debt 4.00% 4.50%
After-tax WACC 6.7% 9.2%
Selected WACC 8.0%

THRN's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for THRN:

cost_of_equity (8.10%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.64) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.